MacGlashan D Jr - Search Results

1

A phase II study of Bruton's tyrosine kinase inhibition for the prevention of anaphylaxis.

Suresh RV, Dunnam C, Vaidya D, Wood RA, Bochner BS, MacGlashan DW Jr, Dispenza MC. Suresh RV, et al. Among authors: macglashan dw jr. J Clin Invest. 2023 Aug 15;133(16):e172335. doi: 10.1172/JCI172335. J Clin Invest. 2023. PMID: 37384412 Free PMC article. Clinical Trial.

2

Bruton's tyrosine kinase inhibition for the prevention of anaphylaxis: an open-label, phase 2 trial.

Suresh RV, Dunnam C, Vaidya D, Wood RA, Bochner BS, MacGlashan DW Jr, Dispenza MC. Suresh RV, et al. Among authors: macglashan dw jr. Res Sq [Preprint]. 2023 Apr 5:rs.3.rs-2757218. doi: 10.21203/rs.3.rs-2757218/v1. Res Sq. 2023. PMID: 37066249 Free PMC article. Updated. Preprint.

3

Association of a SYK promoter polymorphism with SYK expression and IgE-mediated histamine release.

MacGlashan D Jr, Gao L. MacGlashan D Jr, et al. Clin Exp Allergy. 2023 May;53(5):573-576. doi: 10.1111/cea.14289. Epub 2023 Feb 1. Clin Exp Allergy. 2023. PMID: 36722389 Free PMC article. No abstract available.

4

Biological screening of a unique drug library targeting MRGPRX2.

Yang F, Limjunyawong N, Peng Q, Schroeder JT, Saini S, MacGlashan D Jr, Dong X, Gao L. Yang F, et al. Among authors: macglashan d jr. Front Immunol. 2022 Oct 21;13:997389. doi: 10.3389/fimmu.2022.997389. eCollection 2022. Front Immunol. 2022. PMID: 36341461 Free PMC article.

5

Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels.

MacGlashan D Jr, Alvarez-Arango S, Tversky J. MacGlashan D Jr, et al. Clin Exp Allergy. 2021 Aug;51(8):1093-1095. doi: 10.1111/cea.13977. Epub 2021 Jul 20. Clin Exp Allergy. 2021. PMID: 34192382 Free PMC article. No abstract available.

6

Response of peripheral blood basophils in subjects with chronic spontaneous urticaria during treatment with omalizumab.

MacGlashan D Jr, Saini S, Schroeder JT. MacGlashan D Jr, et al. J Allergy Clin Immunol. 2021 Jun;147(6):2295-2304.e12. doi: 10.1016/j.jaci.2021.02.039. Epub 2021 Mar 12. J Allergy Clin Immunol. 2021. PMID: 33716077

7

The efficacy of omalizumab treatment in chronic spontaneous urticaria is associated with basophil phenotypes.

Johal KJ, Chichester KL, Oliver ET, Devine KC, Bieneman AP, Schroeder JT, MacGlashan DW Jr, Saini SS. Johal KJ, et al. Among authors: macglashan dw jr. J Allergy Clin Immunol. 2021 Jun;147(6):2271-2280.e8. doi: 10.1016/j.jaci.2021.02.038. Epub 2021 Mar 10. J Allergy Clin Immunol. 2021. PMID: 33713769 Free PMC article.

8

Vancomycin immediate skin responses in vancomycin-naïve subjects.

Alvarez-Arango S, Oliver E, Tang O, Saha T, Keet CA, Adkinson NF Jr, MacGlashan DW Jr. Alvarez-Arango S, et al. Among authors: macglashan dw jr. Clin Exp Allergy. 2021 Jul;51(7):932-935. doi: 10.1111/cea.13850. Epub 2021 Feb 21. Clin Exp Allergy. 2021. PMID: 33576098 Free PMC article. No abstract available.

9

The relationship between released soluble FceRI-alpha and its cell surface density on human basophils.

MacGlashan D Jr. MacGlashan D Jr. PLoS One. 2021 Jan 22;16(1):e0245942. doi: 10.1371/journal.pone.0245942. eCollection 2021. PLoS One. 2021. PMID: 33481953 Free PMC article.

10

Targeting the FcεRI Pathway as a Potential Strategy to Prevent Food-Induced Anaphylaxis.

Dispenza MC, Bochner BS, MacGlashan DW Jr. Dispenza MC, et al. Among authors: macglashan dw jr. Front Immunol. 2020 Dec 17;11:614402. doi: 10.3389/fimmu.2020.614402. eCollection 2020. Front Immunol. 2020. PMID: 33391286 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

210 results

Search Page